Available by prescription only, mycophenolate mofetil (CellCept®) is a medication approved for preventing organ rejection after a liver, heart, or kidney transplant. It works by making the immune system less active, so the body is less likely to attack and reject a newly transplanted organ.
Mycophenolate mofetil comes in the form of capsules, tablets, an oral liquid suspension, and an intravenous (IV) injection. Your specific dosage will depend on things like your age, your current medications, and how you respond to the medicine. Although most people tolerate it well, side effects may occur and can include swelling, pain, and high blood pressure.
(Click Mycophenolate Mofetil for more information on what this medication is used for, available strengths, and what your healthcare provider needs to know before starting treatment. You can also click any of the links in the box to the right for specific information.)
HealthSavvy Sign In
|